Related references
Note: Only part of the references are listed.Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection
Michael P. Weekes et al.
SCIENCE (2013)
Efficient Human Cytomegalovirus Reactivation Is Maturation Dependent in the Langerhans Dendritic Cell Lineage and Can Be Studied using a CD14+ Experimental Latency Model
Margaret M. Huang et al.
JOURNAL OF VIROLOGY (2012)
Inhibition of Inflammatory Interleukin-6 Activity via Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells
Matthew B. Reeves et al.
JOURNAL OF VIROLOGY (2011)
Human cytomegalovirus immunity and immune evasion
Sarah E. Jackson et al.
VIRUS RESEARCH (2011)
Human cytomegalovirus latent infection and associated viral gene expression
Barry Slobedman et al.
FUTURE MICROBIOLOGY (2010)
Experimental human cytomegalovirus latency in CD14+ monocytes
Danna Hargett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients Reply
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Latency and reactivation of human cytomegalovirus
John Sinclair et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immuno suppression, immune evasion, and latency
Mariana G. Bego et al.
EXPERIMENTAL HEMATOLOGY (2006)
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
EO Kvale et al.
BLOOD (2006)
An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling
MB Reeves et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers
MB Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5
S Varani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation
KS Peggs et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells
M Moutaftsi et al.
JOURNAL OF VIROLOGY (2004)
Pathogenesis and prenatal diagnosis of human cytomegalovirus infection
MG Revello et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking
M Peiser et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form
SF Khaiboullina et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality
WLW Chang et al.
JOURNAL OF VIROLOGY (2004)
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83
B Sénéchal et al.
BLOOD (2004)
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus
L Hertel et al.
JOURNAL OF VIROLOGY (2003)
Characterization of human blood dendritic cell subsets
KPA MacDonald et al.
BLOOD (2002)
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency
FD Goodrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors
B Slobedman et al.
BLOOD (2002)
NF-κB -: A potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
S Prösch et al.
BIOLOGICAL CHEMISTRY (2002)
Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells
U Grigoleit et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells
M Moutaftsi et al.
BLOOD (2002)
Targeting the function of mature dendritic cells by human cytomegalovirus:: A multilayered viral defense strategy
MJ Raftery et al.
IMMUNITY (2001)
Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells
PA MacAry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus
S Riegler et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Share Paper
